Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Coconut Oil × Clear all

Phase

Phase EARLY_PHASE1 1

Status

Withdrawn 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urogenital Abnormalities 1 Urinary Tract Infections 1 Dysuria 1 Dyspareunia 1

Interventions

Cyclophosphamide 344 Carboplatin 291 pembrolizumab 273 Gemcitabine 272 Cisplatin 268 Radiotherapy 260 Paclitaxel 254 Docetaxel 250 Bevacizumab 216 Rituximab 202 Capecitabine 194 Nivolumab 183 Dexamethasone 174 Fluorouracil 171 fludarabine 157 Oxaliplatin 150 Doxorubicin 137 Leucovorin 128 Irinotecan 128 Pemetrexed 124 Etoposide 124 Cytarabine 122 fludarabine phosphate 112 Bortezomib 111 Lenalidomide 109 Cetuximab 107 Filgrastim 106 Erlotinib Hydrochloride 100 Temozolomide 97 Radiosurgery 95

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03185169 2018-07-26

GSM

Alta Bates Summit Medical Center

Phase EARLY_PHASE1 Terminated

Dyspareunia, Urinary Tract Infections, Urogenital Abnormalities, Dysuria

Data powered by HemOnc (CC BY 4.0) Colophon ⚡